Kamlesh Haribhakti
Chief Tech/Sci/R&D Officer at Vensun Pharmaceuticals, Inc.
Profile
Kamlesh Haribhakti is currently the Director, Chief Scientific Officer & EVP at Vensun Pharmaceuticals, Inc. He previously worked as the Director-Product Development at Able Laboratories, Inc.
Kamlesh Haribhakti active positions
| Companies | Position | Start |
|---|---|---|
Vensun Pharmaceuticals, Inc.
 Vensun Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vensun Pharmaceuticals, Inc. engages in the development, manufacture, and supply of generic prescription drugs. It offers Crisoprodol tablets, Clopidogrel tablets, Donepezil Hydrochloride, Fluoxetine Capsules, Nystatin Topical powder, and Pramipexole Dihydrochloride tablets. The company was founded in July 2011 and is headquartered in Yardley, PA. | Chief Tech/Sci/R&D Officer | - |
Former positions of Kamlesh Haribhakti
| Companies | Position | End |
|---|---|---|
| ABLE LABORATORIES INC. | Sales & Marketing | 2007-12-06 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| Able Laboratories, Inc. | Health Technology |
Vensun Pharmaceuticals, Inc.
Vensun Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vensun Pharmaceuticals, Inc. engages in the development, manufacture, and supply of generic prescription drugs. It offers Crisoprodol tablets, Clopidogrel tablets, Donepezil Hydrochloride, Fluoxetine Capsules, Nystatin Topical powder, and Pramipexole Dihydrochloride tablets. The company was founded in July 2011 and is headquartered in Yardley, PA. | Health Technology |
- Stock Market
- Insiders
- Kamlesh Haribhakti
